Skip to main content
. 2008 Jan 29;23(5):509–516. doi: 10.1007/s11606-008-0515-2

Figure 2.

Figure 2

Incremental costs and outcomes of initial treatment with amlodipine versus chlorthalidone for 500 bootstrap samples. Amlodipine was more expensive in all (100%) samples, amlodipine had a better outcome in 84%, and the cost per LY gained was less than $50,000 in 49%. Points to the right of the diagonal line indicate samples where amlodipine was cost-effective at a threshold of $50,000 per LY gained.